Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

  1. Fernandez-Plana, J.
  2. Pericay, C.
  3. Quintero, G.
  4. Alonso, V.
  5. Salud, A.
  6. Mendez, M.
  7. Salgado, M.
  8. Saigi, E.
  9. Cirera, L.
  10. Cirera, L.
  11. Losa, F.
  12. Salud, A.
  13. Gay, M.
  14. Méndez, M.
  15. Alfaro, J.
  16. Vicente, P.
  17. Quintero, G.
  18. Salgado, M.
  19. Jorge, M.
  20. Grande, C.
  21. de la Cámara, J.
  22. Falcó, E.
  23. Muñoz, C.
  24. Nicolau, M.
  25. Pircher, M.
  26. Núñez, X.
  27. Muñoz-Tudurí, M.
  28. del Val, B.
  29. González-Pérez, E.
  30. Show all authors +
Journal:
BMC Cancer

ISSN: 1471-2407

Year of publication: 2014

Volume: 14

Issue: 1

Type: Article

DOI: 10.1186/1471-2407-14-865 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus